Key Metrics of Geron Corporation
Revenue$237K▼ 60.2% YoYFY 2023
Operating income−$194M▼ 40.0% YoY
Net profit−$184M▼ 29.8% YoY
Shareholders' equity$248M
Market cap$575MGERN · $0.89
Competitors10identified
About Geron Corporation
Sectors
Company details
- Website
- geron.com
- Founded
- 1996
- Listed
- Nasdaq: GERN (since 1996)
Operational Areas of Geron Corporation
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameGeron Corporation
TickerGERN
ExchangeNasdaq
CountryUnited States
SEC CIK0000886744
Listed since1996
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://www.geron.com
US market & SEC filings
GERN · Nasdaq · SEC CIK 0000886744
Last price · 02 Nov 2026
$0.89
−5.48%
Market cap$575M
P/E—On FY 2023 diluted EPS
Volume18,809,306
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 1996
GERN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeFoster City
GSTIN—
Email—
Websitehttp://www.geron.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Geron Corporation
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.